Immunomodulating Effects Depend on Prolactin Levels in Patients with Hyperprolactinemia

Abstract

Prolactin is known to have immune modulatory effects acting through the prolactin receptor, which is present on a variety of immune cells. Certain chemokines contribute to form the type of T helper (Th) preponderance in the immune response. The objective of this work was to assess if hyperprolactinemia not related to pregnancy is associated with changes in circulating levels of chemokines and other immunological markers. In this cross sectional study, 35 patients with hyperprolactinemia (5 men), and 102 healthy blood donors (19 men) were included. Serum levels of Th1- Th2- and Th17-associated chemokines, C-reactive protein, immunoglobulins, and the B cell attracting chemokine CXCL13 were assessed. The hyperprolactinemic group had significantly higher levels of Th2 associated CCL22 (p=0.022), Th17 associated CXCL1 (p=0.001), B cell attracting CXCL13 (p=0.003), and C-reactive protein (p<0.001) compared to controls, and these proteins were also positively correlated with prolactin levels. While differences in CCL22, CXCL1, CXCL13, and C-reactive protein were present in patients with low or moderate hyperprolactinemia, no differences were observed at high (>3600 mU/l) prolactin levels. To evaluate a possible dose-associated response to prolactin, an in vitro model was used, showing prolactin-induced increase in T-helper cell activation at moderate levels, while activation decreased at higher levels. Hyperprolactinemia seems to have several immunomodulatory effects and was associated with increased levels of chemokines associated with Th2 and Th17 responses and B cell attraction. However, patients with greatly increased prolactin had normal levels of chemokines, and in vitro, high levels of prolactin decreased T-helper cell activation.

Rare and Complicated Granulomatous Lobular Mastitis (2000–2023): A Bibliometrics Study and Visualization Analysis

“… 46 Moreover, PRL interferes with immune regulation by inhibiting the negative selection of autoimmune B lymphocytes, thereby promoting autoimmune reactions. 47 Prolactin receptors, widely expressed on immune cells, upon binding to prolactin, activate downstream signaling pathways that control the proliferation, differentiation, secretion, and survival of immune cells. 48 Drug-induced HPRL accounts for a significant portion of cases, with traditional antipsychotics being the most common culprits, associated with an incidence rate of 4.0%-70.0%.…”

Transcriptome-based analysis of human peripheral blood reveals regulators of immune response in different viral infections

“…Therefore, diabetes with insulin resistance can directly contribute to an inadequate immune response, e.g., observed during COVID-19 ( 102 ) and some other severe acute viral infections. Prolactin and its receptors play an important role in regulating innate and adaptive immune responses ( 103 ), particularly in T lymphocyte growth and activation ( 104 , 105 ). Stimulation of angiotensin AT1 receptors is important for T cell activation and adhesion/transmigration through the basal endothelial membrane, whereas angiotensin AT2 receptors limit this effect ( 106 , 107 ).…”

Investigating the association between hyperprolactinemia and thyroid autoimmunity in women

“…However, it has been suggested that PRL levels may have immunomodulatory effects, influencing the immune response and contributing to the development of autoimmune thyroid diseases. 19 Additionally, thyroidreleasing hormone (TRH) stimulates the secretion of both PRL and TSH, which may lead to elevated PRL levels in patients with thyroid dysfunction. 20 The relationship between HPRL and TAI is not fully understood, but several potential mechanisms have been proposed.…”